The intricate network of organs in the human digestive system, which breaks down food and nutrients into energy, is vulnerable to a number of illnesses that can upset its delicate equilibrium. Intense heartburn and the crippling consequences of Crohn's disease are only two examples of the millions of people affected by gastrointestinal (GI) problems globally. Nevertheless, a vibrant area of study and invention called "gastrointestinal therapeutics" exists among these difficulties. Join us as we explore the current trends, obstacles, and exciting advancements in this fascinating field.
BCC Research projects that the gastrointestinal (GI) therapeutics and diagnostics global market is estimated to rise from USD 86.0 billion in 2023, to a projected USD 122.5 billion by 2028, at a compound annual growth rate CAGR of 7.3 % during the period of forecast between 2023 and 2028.